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Chromatid Segregation at Anaphase Requires the
barren Product, a Novel Chromosome-Associated
Protein That Interacts with Topoisomerase II
Manzoor A. Bhat,* Alastair Valentine Philp,† as a “glue.” If an inhibitor of the mitosis-specific ubiqui-
tin-dependent proteolytic system (methyl-ubiquitin) orDavid M. Glover,† and Hugo J. Bellen*
a competitor (an N-terminal cyclin fragment containing*Howard Hughes Medical Institute
the destruction box) is added to a Xenopus cell-freeDepartment of Molecular and Human Genetics
system, chromatid separation is prevented (Holloway etBaylor College of Medicine
al., 1993; Morin et al., 1994). These observations haveHouston, Texas 77030
led to the idea that the ubiquitin-dependent degradation†CRC Cell Cycle Genetics Group
system acts first on a set of substrates to mediate chro-Department of Anatomy and Physiology
matid separation and then upon the cyclins to mediateUniversity of Dundee
exit from mitosis. Mutations in fizzy prevent both of theseDundee DD1 4HN
processes (Dawson et al., 1995; Sigrist et al., 1995). InScotland
addition, mutations in three rows (D’Andrea et al., 1993;
Philp et al., 1993) and pimples (Stratmann and Lehner,Summary
1996; A. V. P., unpublished data) delay mitosis 15 at
metaphase, preventing sister-chromatid separation.
We have isolated a Drosophila gene, barren (barr), The data suggest that Pimples and Three Rows are
required for sister-chromatid segregation in mitosis. required to release the cohesion between sister centro-
barr encodes a novel protein that is present in prolifer- meres, thereby allowing centromere separation and initi-
ating cells and has homologs in yeast and human. ation of chromatid segregation (Stratmann and Lehner,
Mitotic defects in barr embryos become apparent dur- 1996).
ing cycle 16, resulting in a loss of PNS and CNS neu- In addition to proteins acting as “glues,” catenation
rons. Centromeres move apart at the metaphase– has also been proposed to contribute to sister-chroma-
anaphase transition and Cyclin B is degraded, but tid cohesion. The replication of chromosomal DNA leads
sister chromatids remain connected, resulting in chro- to the catenation of strands of sister chromatids. The
matin bridging. This phenotype is similar to that de- resolution of this catenation by Topoisomerase II is
scribed in TOP2 mutants in yeast. Barren protein local- thought to occur at two steps during the cell cycle: S
izes to chromatin throughout mitosis. Colocalization phase (Murray and Szostak, 1985) and the metaphase–
and biochemical experiments indicate that Barren as- anaphase transition. This explains the requirement for
sociates with Topoisomerase II throughout mitosis DNA Topoisomerase II activity in yeasts and in frog ex-
and alters the activity of Topoisomerase II. Wepropose tracts (Uemura et al., 1987; Holm et al., 1989; Shamu
that this association is required for proper chromo- and Murray, 1992). Furthermore, injection of inhibitors
of Topoisomerase II into Drosophila syncytial embryossomal segregation by facilitating the decatenation of
prevented chromosome segregation at anaphase (Bu-chromatids at anaphase.
chenau et al., 1993). More importantly, anaphase bridg-
ing has been shown in TOP2 mutants of S. pombe,Introduction
indicating a requirement for Topoisomerase II in chro-
matid decatenation in mitosis (Holm et al., 1985; UemuraDuring cell division, it is essential that each cell receives
et al., 1987). In vitro, Topoisomerase II is a rather unspe-a complete set of chromosomes. For proper segregation
cific enzyme, tanglingor disentagling DNA depending onof chromosomes to occur, a number of events must
the DNA concentration (Kreuzer and Cozzarelli, 1980).
first take place. After DNA replication, the chromosomes
Given this, it is likely that its activity in vivo is guided or
must be properly condensed. Chromosomes then be-
controlled by other factors or proteins. These factors or
come attached to spindle microtubules at kinetochores.
proteins may play a role at various stages of the cell
A chromosome correctly attached is thought to be cycle, i.e., during S phase, during chromosome conden-
aligned at the metaphase plate by the balanced tension sation, and during anaphase in chromosome segre-
on the two linked, yet oppositely oriented, kinetochores gation.
(Nicklas, 1988; McIntosh, 1991; Li and Nicklas, 1995). Here, we show that mutations in barr cause a failure
In addition to the role of the spindle apparatus and of chromosomes to segregate correctly at anaphase,
associated motors, the chromosomes themselves play resulting in massive anaphase bridging. barr encodes
an important role in facilitating chromosome segrega- a novel, conserved protein that localizes throughout
tion. Indeed, the ability of these chromosomes to be chromosomes during mitosis. Since Barren associates
aligned at the metaphase plate under tension is thought with Topoisomerase II and affects its activity, we pro-
to require the cohesion of sister chromatids. This cohe- pose that Barren functions in chromatid decatenation
sion is released at anaphase to allow for the proper during the metaphase–anaphase transition.
segregation of sister chromatids (for review, see Miya-
zaki and Orr-Weaver, 1994). Results
Linkages between sister chromatids have been postu-
lated either indirectly through the presence of associ- Mutations in barr, a Complementation Group
ated chromosomal proteins and/or directly through the at 38B, Affect Nervous System Development
DNA itself. It has beensuggested that chromatid separa- The barr gene was identified in a screen designed to
isolate mutations that affect the development of thetion requires thedegradation of specific protein(s) acting
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Figure 1. barr Mutant Embryos Exhibit Severe PNS Defects
(A) Lateral view of a stage 15 wild-type embryo stained with MAb 22C10 to reveal various clusters of peripheral neurons.
(B) A similar view of a barr embryo stained with MAb 22C10 shows a severe reduction in the number of neurons and lack of organization of
the clusters.
(C) A magnified view of three abdominal segments of (A) indicating the neuronal clusters: d, dorsal; l, lateral; v’ and v, ventral. Arrow indicates
the position of five lateral chordotonals.
(D) A magnified view of three abdominal segments of (B). The mutants display a total disarray and loss of PNS neurons and an increase in
their size.
(E) A wild-type stage 8 embryo hybridized with atonal cDNA showing the expression in chordotonal sensory-organ precursors (SOP).
(F) A similar stage barr mutant embryo does not show noticeable difference in expression of atonal, suggesting that chordotonal SOPs are
born in barr mutants. Arrows indicate the atonal positive chordotonal SOPs.
peripheral nervous system (PNS) (see Figures 1A–1D). at 38B1–38B2, except P8/2, which maps at 38B3–38B4.
Complementation tests indicate that the P8/2 insertionWe isolated seven P-element enhancer-detector inser-
tions that cause similar phenotypes (Kania et al., 1995) is in a gene encoding a kinesin-like protein currently
being studied by several laboratories (Luke Alphey, Mar-and fail to complement a smalldeficiency Df(2L)TE38A-1
(38A6–38A7;38B6–38C1). All P-element insertions map garet Fuller, Pedro Ripoll, and Doug Ruden, personal
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communications; David Glover, unpublished results). carried out immunostaining of barrL305 embryos under-
These tests also indicate that the P-element insertions going mitosis 16 to examine spindle morphology, cyclin
in strains P3/10, P139/3, P140/14 and P140/28 affect degradation, and cytokinesis. Cells in the dorsal and
barr only; that P48/5 affects barr and the gene for a ventral epidermis of barr embryos (Figures 2A and 2B)
kinesin-like protein; and that P49/12 affects barr, the enter mitosis 16 normally and undergo chromosome
kinesin-like protein gene, and a third complementation condensation and congression to the metaphase plate
group, TE7, identified by Doug Ruden (personal commu- like wild-type embryos. Similarly, metaphase–anaphase
nication). transition begins correctly both by the initiation of chro-
To ascertain whether the P-element insertions are re- mosome movement and by the degradation of cyclin B
sponsible for the mutant phenotypes, the P elements (inset to Figure 2C). However, in themajority of anaphase
were excised. All P elements that affect barr only were figures, chromatids do not resolve as they do in wild
revertible, whereas the others could not be reverted, type (arrows in Figure 2D) but remain interlocked to
suggesting rearrangements. These experiments also al- form extensive chromatin bridges (arrows in Figure 2B).
lowed us to recover an imprecise excision for P3/10, Subsequently, the unresolved chromatids decondense
barrL305, which behaves as a null allele of barr (see without segregation and cytokinesis is attempted (ar-
below). rows in Figure 2C), the plasma membrane being pinched
All strains homozygous for barr mutations were em- in toward thechromatin bridge. Hence, barr is necessary
bryonic lethal, and their embryos showed a severe loss for correct chromatid segregation but not cell cycle pro-
of PNS neurons and a significant increase in size of gression out of mitosis.
remaining neurons (Figures 1A–1D). Mutant embryos of
strain P8/2 in which the gene for a kinesin-like protein
Centromere Separation Occurs Normallyis affected show only a decrease in the number of neu-
in barr Mutant Embryosrons. On the basis of the phenotypic analysis and the
To examine whether centromere separation can occurcomplementation data, we conclude that 38B1–38B4
in cells of barr embryos, we stained embryos undergoingcontains at least three essential genes, two of which
mitosis 16 with anti-GAGA factor serum (Raff et al.,independently affect the development of the PNS: barr
1994). This serum stains centromeric heterochromatinand a gene encoding a kinesin-like protein.
and, in anaphase figures, labels two areas on chromo-
somes, close to the spindle poles, where the centro-barr Embryos Arrest in Cycle 16
meres lie (Figure 3A). In barr embryos we see centromereThe loss of neurons in barr embryos could be attributed
separation to the poles in some cells (arrows), but into the following: lack of sensory organ precursor (SOP)
others centromeres remain clustered over the centralformation, transformation of neuronal cells into nonneu-
ronal support cells, or failure of SOPs to divide properly. mass of chromatin (arrowhead) (Figure 3B). We also
To determine whether SOPs are specified properly in used the dodecasatellite probe to examine behavior of
barr embryos, we determined whether SOPs of the lat- the centromeric region of chromosome 3 (Carmena et
eral chordotonal neurons are present, since these neu- al., 1993; Sigrist et al., 1995). The inset to Figure 3B
rons are absent in barr embryos (Figures 1A–1D). In situ shows that third-chromosome centromeres (arrows) can
hybridizations with a chordotonal SOP marker (Jarman indeed undergo extensive separation. These observa-
et al., 1993) show similar expression patterns in wild- tions argue that incomplete separation of chromatids
type and barr embryos (Figures 1E and 1F), suggesting in barr embryos is not due to a failure of centromere
that the SOPs of lateral chordotonal neurons are born. separation but rather to some other separation or segre-
To establish whether PNS neurons are transformed into gation defect.
lineage-related support cells, we stained barr embryos
with a glial marker (Vaessin et al., 1991) and a general
Isolation of barrPNS marker (Bellen et al., 1992). These stainings re-
To isolate barr, genomic sequences flanking the P ele-vealed a severe decrease in the total number of PNS
ments were plasmid rescued and used to screen cDNAcells (data not shown). As shown in Figure 1, this de-
and genomic libraries. The longest cDNA obtained iscrease in number of PNS cells is associated with an
2.5 kb, and its 59end is 70 bp downstream of P3/10. Inincrease in size of remaining cells, suggesting a failure
addition, sequence comparisons of genomic and cDNAof cell division (Salzberg et al., 1994). To assess whether
sequences identified a 120 bp intron, 40 bp downstreamthe number of ectodermal cells was reduced, we visual-
of thestart of the cDNA, just prior to theATG start codon.ized all nuclei with a DNA stain and noticed a 50%
PCR and sequence analyses did not reveal additionalreduction of the total number of nuclei in the ectodermof
introns (Figure 4A). The cDNA probably correspondsstage 13 embryos when compared to wild-type embryos
to barr, as in situ hybridization experiments show that(data not shown), suggesting that barr embryos fail to
transcripts were almost absent in strain P3/10 and ab-complete mitosis 16. This failure leads to morphological
sent in barrL305 embryos.defects that are most easily observed in PNS and CNS,
To demonstrate that we cloned barr, the barr cDNAas these cells undergo more cycles than ectodermal
was inserted under the control of a heat-inducible pro-cells.
moter into pCaSpeR-hs. Five different transgenic chro-
mosomes were crossed into the barrL305/CyO flies. Thesebarr Is Required for Complete Segregation
flies were maintained in a cycling incubator at 258C andof Chromosomes
received a 1 hr heat shock (378C) every 6 hr. A significantThe developmental defects of the nervous system sug-
gest a role for barr in cellcycle progression. We therefore number of y w, P{CaSpeR-hs-barr}; barrL305/barrL305 flies
Cell
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Figure 2. Barren Is Required for Chromosomal Segregation
barr embryos (A–C), and their wild-type siblings (D), undergoing mitosis 16 in the ventral and dorsal epidermal tissues. (A), (B), and (D) show
views of an embryo stained with YL1/2 (a rat monoclonal serum that recognizes tyrosinated a-tubulin; green) and propidium iodide (red) to
visualize DNA. (C) and the inset show views of similar embryos stained with propidium iodide (blue) and rabbit sera recognizing cyclin B (red
in inset) and spectrin (yellow in main panel). Cells enter mitosis 16 following the normal pattern (A) and pass through the metaphase–anaphase
transition (m, metaphase; a, anaphase) where cyclin is degraded (arrowheads in inset to [C]). However, although anaphase is initiated, the
two chromosome complements cannot be disentangled from one another. (B) shows an enlargement of the boxed area on (A) and shows
two such affected cells (arrows). The chromatids do not resolve and remain interlocked, forming extensive chromatin bridges rather than
separating cleanly as chromatids do in wild-type embryos (arrowheads in [D]). Although chromatid separation is not completed, cytokinesis
is initiated (arrows in [C]) but fails.
emerged in two independently established transgenic share several key domains and identify a novel family
of proteins.lines. As we never observed non-CyO flies in the barrL305/
CyO (barr L305 causes embryonic lethality), these obser-
vations demonstrate that we have cloned the barr gene. barr Is Expressed in Mitotically Active Cells
In situ hybridization experiments show that barr is ex-
pressed in the wild-type embryo in a pattern similar tobarr Encodes a Novel Protein with Yeast
and Human Homologs other genes essential for cell cycle progression (data
not shown; Lehner and O’Farrell, 1989, 1990; RichardsonThe nucleotide sequence of the barr cDNA contains an
open reading frame (ORF) of 736 aa (predicted 81 kDa). et al., 1993). We did not observe barr in endoreplicating
tissues, which suggests that it does not play a role inSequence homology searches identified two ORFs: a
747 aa human (HSORF 007) and a 728 aa yeast ORF the S and G1 phases. Similar experiments carried out on
barr mutant embryos show that the transcripts observed(SCYBL097W) (Figure 4B) with unknown functions. The
Barren protein shows 27% or 21% identity (I) and 47% prior to stage 10 are at least partly of maternal origin.
The decreased levels of transcripts in stage 8 mutantor 45% similarity (S) with the human and yeast ORF,
respectively. The Drosophila and human proteins have embryos suggest that zygotic transcription is initiated
prior to this stage. Since developmental stages 10 and3 highly conserved domains: one toward the amino ter-
minus 47% I and 77% S (102–135 aa) and two toward 11 correspond to mitotic cycles 15 and 16, we infer that
the absence of zygotic barr transcripts in stage 10 barrthe carboxyl terminus with 50% I and 67% S (619–643
aa) and 49% I and 63% S (699–734 aa). There are 14 mutant embryos causes the division failure observed in
cycle 16.phosphorylation consensus sites for casein kinase, 11
for protein kinase-C, 3 for cAMP- and cGMP-dependent A single 2.6 kb transcript ispresent at all stagesexcept
in imagos where the transcript seems shorter (data notprotein kinase, and one putative nuclear localization se-
quence (KKsahlnanRRaK) (Dingwall and Laskey, 1991). shown). Zygotic expression peaks between 6 and 12 hr
of development and mRNA is present at low levels inFinally, numerous PEST sequences found in rapidly de-
graded proteins are also present in Barren (Rogers et first, second, and third instars and at moderately low
levels in pupae and adults.al., 1986). We conclude that Barren and its homologs
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early development, and we did not observe immunohis-
tochemical staining in stages 15–16 null mutant em-
bryos.
The subcellular distribution of Barren in mitotic do-
mains of mitosis 14 was characterized using confocal
microscopy (Figure 5B). During interphase, some Barren
protein is diffusely distributed throughout the cytoplasm
and little or no protein is present in the nucleus. How-
ever, as chromosomes condense during prophase (p)
and metaphase (m), Barren staining colocalizes with
DNA staining. Throughout prophase, metaphase, and
anaphase (a), the Barren staining persists on chromatin,
but in late telophase (t), the staining of chromatin begins
to disappear. Hence, Barren is associated with chroma-
tin throughout the process of chromatid segregation.
Barren Protein Colocalizes with Topoisomerase II
during Mitosis
It has been proposed that the final rounds of decatena-
tion during metaphase–anaphase transition might be
carried out by Topoisomerase II (TOPOII), allowing chro-
mosome segregation (Holm, 1994). Since barr embryos
display chromosome bridging in anaphase, we sus-
Figure 3. barr Mutations Do Not Prevent Centromere Separation pected that Barren might function by modifying TOPO
barr embryos (B) and their wild-type siblings (A) undertaking mitosis II activity. Using a monoclonal antibody that recognizes
16 in the ventral epidermis were stained with propidium iodide to Drosophila TOPO II (Swedlow et al., 1993) (Figure 6A)
visualize DNA (red) and an antibody that recognizes the GAGA pro-
and anti-Barren serum (Figure 6B), we stained wild-typetein (green in main panels, overlap with red gives yellow). In addition,
embryos undergoing mitosis 14. TOPO II and Barrensome embryos were hybridized with a DNA probe containing the
dodecasatellite sequences shown to be localized specifically near proteins colocalize during prophase (p), metaphase (m),
the centromere of chromosome 3 (green in inset to [B]). The GAGA anaphase (a), and telophase (t). However, although
serum stains centromeric heterochromatin and in wild-type ana- TOPO II associates with chromatin during interphase,
phase figures (arrows in [A]) predominantly stains the areas of ana- Barren does not.
phase figures close to the spindle poles, where the centromeres lie.
To determine whether TOPO II localization is depen-In barr embryos (B), we see centromere separation to the poles in
dent on barr, we stained barrL305 embryos undergoingmany cases (arrows), butnot all (arrowhead). Using the dodecasatel-
lite probe, we observe that the centromeres (arrows) of chromosome mitosis 16 with anti-TOPO II (Figures 6C and 6D). Al-
3 can undergo extensive separation in at least some cases. though the chromatids cannot separate, TOPO II local-
izes to themetaphase plate where the tangled chromatin
lies (arrowheads in Figures 6C and 6D). This indicates
that although Barren may be necessary for the functionBarren Protein Localizes to Chromatin
of TOPO II during chromatid segregation, it is not re-in Mitotically Active Cells
quired for localization of TOPO II to chromatin duringTo determine the cellular and subcellular localization
mitosis.of the Barren protein, we raised polyclonal antibodies
against the entire ORF encoded by the cDNA. The anti-
bodies recognized a 97 kDa protein in in vitro–translated Barren and Topoisomerase II Interact
and bacterially expressed protein lysates (Figure 5A, In Vitro and In Vivo
lanes 1 and 2). On Western blots of individual, wild-type, To determine whether Barren and TOPO II form a protein
stage 14 embryos, the antibodies recognized a 97 kDa complex, we carried out immunoprecipitation experi-
protein band and two bands of lower molecular weight ments with anti-Barren antibodies. Embryonic extracts
(MW) (Figure 5A, lane 3). The intensities of the 97 kDa (0–12 hr old) were immunoprecipitated with anti-Barren
band and the lower MW bands were greatly reduced in antibody and resolved by SDS–PAGE. The blots were
wild-type stage 16 embryos, when compared to stage first probed with anti-Barren antibody to demonstrate
14 embryos (compare in Figure 5A, lanes 3 and 4). Stage that this antibody can immunoprecipitate Barren under
16 mutant embryos did not show the 97 kDa protein stringent washing conditions (Figure 6E, lanes 1 and 2).
band (Figure 5A, lane 5). In addition, the lower MW bands Barren was below detectable levels in immunodepleted
are also greatly reduced in Western blots of single mu- extracts as compared to embryonic extract prior to im-
tant stage 16 embryos. Hence, we propose that the munoprecipitation (Figure 6E, compare lanes 3 and 4).
lower MW bands represent degradation products of the Immunoblotting with anti-TOPO II antibody identified
maternally contributed or maternally and zygotically TOPO II in anti-Barren immunoprecipitated complexes
contributed Barren protein in mutant and wild-type em- (Figure 6F, lanes 1 and 2) and embryonic extracts (lane
bryos, respectively. 3). TOPO II was absent from immunoprecipitated com-
Immunohistochemical staining of wild-type embryos plexes obtained with preimmune sera under identical
conditions (Figure 6F, lane 4). These data suggest thatshowed that Barren protein is present in all cells during
Cell
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Figure 4. Map and Sequence Comparison of barr and Its Homologs
(A) The 38B region. The arrow indicates the position of the P-element insertions P3/10, P139/3, P140/14, P48/5, and P49/12. A 33 kb genomic
region was isolated by a combination of plasmid rescue and chromosome walking. The P3/10 transposon insertion site is indicated in the
genomic map by a triangle. The genetic data suggested that barr is in close proximity to KLP38B that has been independently cloned by the
laboratories of Minx Fuller, Pedro Ripoll, Doug Ruden, Luke Alphey, and David Glover (personal communications). KLP38B cDNA maps 14
kb from barr and is transcribed in the opposite orientation. Restriction sites are: H, HindIII; R, EcoRI; S, SalI.
(B) Sequence alignment between Barren (Dm) and its human (Hs) and yeast (Sc) homologs. Amino acids shown in bold are either conserved
among all three proteins or Barren and another homolog.
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Figure 5. Localization of Barren in Proliferating Cells during Mitosis
(A) Single embryos of barr1 and barr L305 were analyzed on an 8% SDS–polyacrylamide gel followed by Western blotting. Lane 1, the anti-
Barren antiserum identified a single protein band migrating at 97 kDa in in vitro–translated lysates. Lane 2, expression of Barren in bacteria
also produces a 97 kDa band and two other smaller MW bands. Lanes 3 and 4 each contain single wild-type stage 14 and stage 16 embryos,
respectively. The antiserum recognizes a 97 kDa band and two lower MW bands of 46 and 48 kDa. The amount of Barren protein has decreased
in stage 16 embryos. Lane 5, most bands including the 97 kDa band are absent or reduced in stage 16 barr null embryos suggesting that the
46 and 48 kDa bands are degradation products of Barren.
(B) Mitotic figures in early mitosis 14 domains stained with anti-Barren antibody (green) and propidium iodide (purple). During prophase (p),
metaphase (m), and anaphase (a) Barren staining persists on chromatin, but as telophase (t) proceeds the staining of chromatin starts to fade
away.
TOPO II and Barren are part of a protein complex. These Barren Activates Topoisomerase II Activity
Given that three independent assays indicate that Bar-complexes do not contain proteins like b-tubulin and
histones, as established by Western blotting. Reciprocal ren interacts with TOPO II, we investigated whether Bar-
ren protein alters TOPO II activity. Barren protein wasimmunoprecipitations with four different antibodies
raised against full-length or domains of TOPO II were affinity purified from 0 to 16 hr embryos using anti-
Barren antibody covalently linked to activated Sepha-unsuccessful due to their inability to immunoprecipitate
TOPO II. rose. The eluate was highly enriched for Barren protein
and had no detectable levels of TOPO II as detected byTo further establish whether Barren and TOPO II inter-
act, we produced a recombinant GST-Barren fusion pro- Western analysis and silver staining (data not shown).
This Barren eluate was used in a DNA relaxation assaytein and immobilized it on glutathione-agarose resin.
The immobilized GST alone or GST-Barren were incu- in the presence and absence of TOPO II. As shown in
Figure 6I, small amounts of the Barren eluate stronglybated with embryonic extract. Immunoblotting revealed
the presence of TOPO II following elution of GST-Barren activate Topoisomerase II activity, whereas higher pro-
tein concentrations inhibit TOPO II activity. Note that atbound proteins after extensive washing and elution with
up to 100 mM NaCl. TOPO II was not present in the lower concentrations of the Barren protein eluate, all
supercoiled DNA is converted to topoisomers (Figureeluate of GST-resin (data not shown).
To determine whether the two proteins can interact 6I, lanes 3 and 4). However, as the concentration of the
Barren eluate increases, we observe first weak, thenin vivo, we carried out a yeast two-hybrid interaction
assay. We constructed fusions of Barren and TOPO II strong inhibition of TOPO II activity (lanes 6 and 7 with
100 and 200 ng of Barren eluate). The Barren eluate alsowith both the GAL4 DNA-binding domain (using pAS2-
CYH2) and the GAL4 activation domain (using the contains an activity that nicks a minor fraction of the
supercoiled DNA. This activity increases with increasingpACT2) (Durfee et al., 1993). Each of the single trans-
formants grows on the appropriate single deficient me- amounts of Barren eluate and perhaps affects TOPO II
activity.dia (Figure 6G, sectors a and b, c and d) and does not
activate the transcription of the b-galactosidase re- As the Barren eluate activates TOPO II, we wanted to
establish whether the nicking activity and TOPO II–porter gene (Figure 6H, sectors a–d). The pAS2-CYH2-
barr containing strain was transformed with pACT2-topo promoting activity are due to the same protein and
whether these activities could be blocked by purifiedII DNA, and the pAS2-CYH2-topo II containing strain
was transformed with pACT2-barr DNA. Double trans- anti-Barren antibodies. As shown in Figure 6J (lane 4),
no nicking activity was observed when purified anti-formants containing pAS2-CYH2-barr and pACT2-topo
II (Figure 6G, sector e) or pAS2-CYH2-topoII and pACT2- Barren antibodies were added to DNA. The Barren elu-
ate, in the absence of anti-Barren antibody, had somebarr (Figure 6G, sector f) were able to grow on medium
that lacked His, Leu, and Trp showing that the HIS gene nicking ability (lane 5) that was not blocked by anti-
Barren antibody (lane 1, 5 ng; lane 2, 10 ng; lane 3, 50is induced. In addition, these colonies express b-galac-
tosidase (Figure 6H, sectors e and f, respectively). Thus, ng). This suggests that this minor nicking activity is due
to a contaminating protein in the Barren eluate. Alterna-the yeast two-hybrid interaction assay further estab-
lished that the two proteins interact. tively, this activity may be due to a degradation product
Cell
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Figure 6. Barren Colocalizes, Interacts with, and Activates TOPO II
(A–D) Wild-type embryos at mitosis 14 (A and B) and barr L305 embryos at mitosis 16 (C and D) were stained with anti-TOPO II ([A], green in
[D]), anti-Barren (B) and propidium iodide ([C], red in [D]) to visualize DNA. Both TOPO II (A) and Barren (B) are associated with mitotic figures
from prophase (p) through metaphase (m), anaphase (a) to telophase (t). Although TOPO II is associated with chromatin in interphase, Barren
is not (compare arrowheads). TOPO II (green, Figure 7D) still accumulates on elongated anaphase figures (arrows) even in the absence of
Barren protein.
(E) Embryonic extracts (0–12 hr old) immunoprecipitated with anti-Barren antibody. The washing conditions used after immunoprecipitations
are indicated. The immunoprecipitates were resolved by SDS–PAGE. Immunoblotting with anti-Barren antibody demonstrates that Barren (97
kDa with arrow) is immunoprecipitated (lanes 1 and 2). Barren is not present in the supernatant after immunoprecipitation (lane 3) but is
present in extracts before immunoprecipitation (lane 4).
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of Barren or a Barren activity that is not blocked by the and CNS where divisions beyond cycle 16 require zy-
gotic transcription, e.g., barr mutants. In addition tobarr,anti-Barren antibody.
To determine whether the TOPO II–promoting activity we have identified another gene at 38B that affects PNS
development and encodes a kinesin-like protein. Mu-in Barren eluate was due to Barren, we carried out the
experiments shown in Figure 6J, lanes 6–8, using anti- tants of this gene also lack PNS neurons and display
mitotic defects.Barren antibody. Lane 6 shows topoisomers produced
from supercoiled DNA incubated with TOPO II. Lane 7
shows a reaction identical to that in lane 6, except that barr Encodes a Conserved Protein
The Barren protein is conserved from yeast to man and30 ng of Barren eluate was added. Note the shift toward
more relaxed topoisomers induced by the Barren eluate. is likely to play a role in cell cycle progression in other
species as well. No data exist on the roles of theseLane 8 shows the same reaction as in lane 7 in the
presence of 50 ng of anti-Barren antibody. The activa- proteins in other organisms. The presence of PEST se-
quences suggests that Barren can be rapidly degraded.tion of TOPO II activity due to Barren eluate as shown
in lane 7 was completely blocked. We conclude that The lethal phases of mutations in barr, fizzy (Dawson et
al., 1995; Sigrist et al., 1995), three rows (D’Andrea etBarren eluate contains an activity that stronglyenhances
the ability to relax supercoiled DNA by TOPO II, and that al., 1993; Philp et al., 1993), and pimples (Stratmann
and Lehner, 1996) suggest that the respective proteinthis activity can be blocked specifically by anti-Barren
antibody. The anti-Barren antibody itself has no activity products are degraded rapidly. The degradation of Bar-
ren protein may be important in permitting cells to differ-in the presence or absence of Topoisomerase II and in
the absence of Barren protein eluate. These data sug- entiate as they leave the cycle. However, our initial im-
munostaining of wild-type embryos with anti-Barrengest that the Barren protein promotes the relaxation
activity of Topoisomerase II in vitro. antibody suggests that degradation may not occur until
the end of mitosis.
Discussion
Anaphase Defects in barr
Mutations in barr prevent effective separation of sisterMutations Affecting PNS Development
Permit Isolation of Cell Division Genes chromatids during anaphase. The progression of the
mitotic cycle up to anaphase does not appear to beA previous screen for mutations that affect the develop-
ment of the PNS led to the isolation of mutations that affected. Chromosome condensation and congression
onto the metaphase plate occurs, and this is followed bycause a decrease in total number of PNS neurons and
a concomitant increase in size of remaining neurons chromosome movement toward the poles at anaphase.
This suggests that the spindle and associated molecular(Salzberg et al., 1994). A similar phenotype was ob-
served in barr mutant embryos (Kania et al., 1995). Salz- motors are functioning correctly in the mutant. More-
over, the kinetochore would seem not to be affected inberg et al. (1994) suggested that the giant neuron pheno-
type was caused by defects in cell division. The the mutant since it allows normal attachment of the
chromosomes to the spindle, permitting them to movephenotype of barr mutants is consistent with this hy-
pothesis as the embryos fail to proceed beyond mitosis to the metaphase plate. Furthermore, the kinetochore
seems able to signal chromosome alignment, a mecha-16. The first 13 nuclear division cycles of the syncytial
embryo are driven by maternal components. If the ma- nism monitored by tension (Ault and Rieder, 1994; Li
and Nicklas, 1995), that triggers anaphase. Anaphaseternal components are relatively stable, they may be
sufficient for development to third-instar larvae (Gatti appears to be initiated correctly both by chromosome
movement and the degradation of Cyclin B with theand Baker, 1989). In other mutants, lack of zygotic tran-
scripts may result in a mutant phenotype in the early appropriate timing. This suggests that the mutation does
not grossly affect the ubiquitin-dependent proteolyticpostblastoderm cycles, e.g., string (Edgar and O’Farrell,
1989). If cycles 14 and 15 proceed normally, a dramatic system required for anaphase onset.
Our studies using anti-GAGA antibodies indicate thatphenotype is not seen in most tissues, except in PNS
(F) Barren immunoprecipitates were resolved on SDS–PAGE and immunoblotted with anti-TOPO II, demonstrating the presence of TOPO II
(160 kDa with arrow, lanes 1 and 2). The same band is present in embryonic extract alone (lane 3). TOPO II was not detected in complexes
immunoprecipitated with preimmune serum under identical conditions (lane 4).
(G and H) Results of the yeast two-hybrid interaction assay. (a) pAS2-CYH2-barr grown on SC-Trp, (b) pAS2-CYH2-topo II grown on SC-Trp,
(c) pACT2-barr grown on SC-Leu, (d) pACT2-topo II grown on SC-Leu, (e) pAS2-CYH2-barr and pACT2-topo II, and (f) pAS2-CYH2-topo II
and pACT2-barr grown on SC-His,-Leu,-Trp. Single transformants in sectors (a)–(d) were negative for b-galactosidase activity. Only double
transformants in sectors (e) and (f) were positive for b-galactosidase activity.
(I) Effect of Barren protein eluate on TOPO II activity. Lane 1 shows control 300 ng of supercoiled pBR322 DNA without TOPO II or Barren
protein eluate. Lanes 2–8 contain 300 ng DNA, 4 units of TOPO II and 1, 10, 20, 50, 100, 200 ng and no Barren protein eluate, respectively.
(J) Affinity-purified anti-Barren antibody blocks the Barren-induced activation of TOPO II activity. All lanes contain 300 ng of pBR322 DNA.
Lanes 1–3 contain, in addition to DNA, 30 ng of Barren protein eluate and 5, 10, and 50 ng of anti-Barren antibody, respectively. The Barren
protein eluate has weak nicking activity that is not blocked by anti-Barren antibody. Lane 4 contains DNA and 30 ng of anti-Barren antibody
and no Barren protein eluate. The antibody has no nicking activity, and this lane is similar to a lane that contains DNA alone (see lane 1 of
Figure 6I). Lane 5 contains DNA and 30 ng of Barren protein eluate in the absence of anti-Barren antibody. Lane 6 contains DNA and 4 units
of TOPO II. Lane 7 contains 4 units of TOPO II and 30 ng Barren protein. Note the enhanced activity of TOPO II. Lane 8 contains 4 units of
TOPO II, 30 ng of Barren protein eluate, and 50 ng of anti-Barren antibody. Note that the enhanced activity caused by Barren protein eluate
is completely blocked.
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the centromeric regions of the chromosomes are able to addition, biochemical assays show that eluate of affin-
ity-purified Barren protein strongly enhances TOPO IIseparate. Thus, many aspects of metaphase–anaphase
transition, including chromatid separation at the kineto- activity and that this activity can be blocked with purified
anti-Barrenantibody. It will beof future interest tosearchchores, are taking place correctly. However, sister chro-
matids do not separate and appear to remain linked at for other components that regulate chromosome de-
catenation, providing a route toward understanding themultiple sites along the length of the chromosomes.
Sister-chromatid cohesion has been postulated to re- molecular componentsof thedecatenation process dur-
ing mitosis.sult from the intertwining of sister DNA molecules and/
or a hypothetical cohesive protein at the centromere
(reviewed in Miyazaki and Orr-Weaver, 1994). The failure Experimental Procedures
of chromatids to separate could be caused by a defect
Immunohistochemistry, Immunofluorescence,in either of these mechanisms. However, the fact that
and Confocal Microscopywe frequently observeseparation of centromeric regions
Embryos were collected, dechorionated, treated with taxol, fixed inin barr suggests that the mitotic defect results from
4% freshly prepared paraformaldehyde, and devitellinized in metha-
chromosome arms remaining attached along their nol as previously described in Philp et al. (1993). The following
length, suggesting that decatenation of replicated chro- primary antibodies were used: MAb 22C10 (1:200; Zipursky et al.,
mosomes is not taking place. This led us to consider 1985); anti-Prospero (1:200; Vaessin et al., 1991); anti-Couch Potato
(1:5000; Bellen et al., 1992); Rb271 anti-Cyclin B (1:500; Whitfield etthe possibility that the Barren protein is regulating the
al., 1989); YL1/2 anti-a-Tubulin (1:500; Kilmartin et al., 1982); anti-activity of TOPO II, noting that centromere separation
Spectrin (1:250; Byers et al., 1987); anti-GAGA (1:500; Raff et al.,is still observed in topoisomerase II mutants in S. pombe
1994); and anti-TOPO II (MAb P2G3, 1:10; Swedlow et al., 1993).
(Funabiki et al.,1993). To our knowledge, topoisomerase Images were captured using a Bio-Rad MRC 600 laser-scanning
II mutants in Drosophila have not been identified. How- confocal microscope.
ever, inhibition of TOPO II prevents complete chromatid
separation in syncytial embryos (Buchenau et al., 1993). Isolation of the barr cDNA
Even in the absence of barr function, TOPO II localizes The genomic sequences flanking the 3/10, 140/14, and 139/3
P-element insertions were recovered by plasmid rescue (Wilson etto chromatin and is concentrated at the site of tangled
al., 1989). All of the genomic phages hybridizing to the barr cDNADNA on the metaphase plate. Hence, Barren does not
were analyzed by PCR to verify the presence of intronic sequences.seem to be required for localization of TOPO II to the
The primer sequences were 59-CTGTCGATTTGGGATCACAGT-39
chromosomes. Interestingly, TOPO II localization stud- and 59-CGACTGGGGTGAGGATATCTGT-39 from the 59 and 39 ends
ies carried out by Swedlow et al. (1993) have shown of barr cDNA, respectively.
that the enzyme exists in different pools. One of these
pools seems necessary for chromosomal condensation, Generation of Antibodies to Barren and Western Analysis
whereas another pool seems to function at the time of The full-length barr cDNA was cloned into the pET-28a(1) expres-
sion vector (Novagen) to make a His-tag fusion protein. The inducedchromosome segregation, suggesting different func-
protein was resolved by electrophoresis and excised from the gel.tions for these enzyme pools (Swedlow et al., 1993).
The protein was eluted in PBS and injected into rabbits. The immuneHence, Barren may modify the function of TOPO II by
serum was used for Western analyses at 1:3000 and for immunohis-
acting as a positive regulator for chromosomal segre- tochemistry at 1:2000.
gation.
The need to resolve the DNA of newly replicated chro- Immunoprecipitation
matids arises from the topological difficulties in replicat- For immunoprecipitation, embryonic extracts were prepared by ho-
ing a linear chromosomal DNA molecule from multiple mogenizing 0–12 hr old embryos in immunoprecipitation buffer (IPB)
(25 mM HEPES [pH 7.5], 100 mM NaCl, 1 mMCaCl2, 1 mM MgCl2,origins. The barr defect could therefore arise in the pro-
0.5% Triton X-100, 1 mM PMSF, 5 mM leupeptin, 1 mM pepstatin,cess of DNA replication. If so, this must be a type of
0.3 mM aprotinin) using a Dounce homogenizer. The homogenateerror that would escape the checkpoint mechanisms
was filtered through Nytex mesh to remove debris and centrifugedthat monitor completeness of DNA replication, as mu-
at 20,000 3 g followed by another centrifugation step at 100,000 3
tant cells not only enter mitosis but also proceed cor- g for 1 hr at 48C. The supernatant was cleared of floating lipid layer
rectly to metaphase. These data strongly suggest that and dilutedwith IP buffer containing 10 mg/ml BSA (IPB). The extract
was first cleared with a 50% slurry of Protein A-Sepharose (PAS) inthe defect is at anaphase per se. Furthermore, the ab-
IPB and incubated with anti-Barren antibody or preimmune serumsence of Barren in tissues undergoing rounds of endo-
for 2 hr at 48C with slow tumbling, followed by addition of PAS, andreplication also argues against a requirement for the
continuedfor another3 hr. The immunoprecipitated complexeswereprotein during S phase. The failure of decatenation of
pelleted by brief centrifugation and washed as follows: two washes
replicated chromatids may not be of consequence to in IPB, one wash in IPB with 300 mM NaCl, one wash in IPB with
the structure of polytene chromosomes, or there may 500 mM NaCl, one wash in IPB with 500 mM NaCl and 1% Triton
be tissue-specific isoforms of Barren-like proteins that X-10, one wash with IPB and a final wash with 10 mM Tris-HCl buffer
(pH 7.5). The complexes were suspended in SDS–sample buffer andcan supply this function. Our finding that the Barren
boiled for 5 min and resolved by SDS–PAGE followed by Westernprotein colocalizes with TOPO II and associates with
blotting as described above. The anti-TOPO II antibodies were usedcondensed chromosomes until the end of mitosis sug-
at 1:10,000 dilution (Whalen et al., 1991).
gests that it is a chromosomal protein that plays a direct
role in regulating the terminal cycles of decatenation
Two-Hybrid Interaction Assay
of chromosomal arms. Our observations are consistent pAS2-CYH2-barr and pAS2-CYH2-topo II and pACT2-barr and
with this model, as immunoprecipitations, affinity chro- pACT2-topo II were constructed by PCR amplification of complete
matography using GST-Barren, and yeast two-hybrid ORFs of barr and topo II. Yeast strain HF7c (Feilotter et al., 1994)
was transformed with the above plasmids. All yeast manipulationsassays indicate that Barren and TOPO II interact. In
Barren Is Required for Chromosomal Segregation
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were as described in Durfee et al. (1993). Single plasmid trans- neuronal precursors and shows homology to RNA-binding proteins.
Genes Dev. 6, 2125–2136.formants were checked for their growth on appropriate single selec-
tion plates, as well as on double selection plates. Following sequen- Buchenau, P., Saumweber, H., and Arndt-Jovin, D.J. (1993). Conse-
tial transformations of the plasmids in various combinations on quences of TOPO II inhibition in early embryogenesis of Drosophila
media lacking His, Leu, and Trp, His1 colonies were tested for revealed by in vivo confocal laser scanning microscopy. J. Cell Sci.
b-galactosidase activity. 104, 1175–1185.
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Affinity Chromatography with Immobilized L.S. (1987). Drosophila spectrin, II. Conserved features of the
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